|
|
Post by agedhippie on Sept 14, 2019 9:41:35 GMT -5
What Sanofi and Novo Nordisk are doing is interesting. Both have an offer where for $99 you can get both basal AND bolus insulin (Toujeo and Apidra, or Tresiba and Fiasp or Novolog). This clever because it disadvantages manufacturer making only a meal time insulin (although I think the real target here is Eli Lilly rather than Mannkind) as their customers still need to buy a basal insulin which makes that route a lot more expensive.
|
|
|
|
Post by peppy on Sept 14, 2019 11:26:28 GMT -5
What Sanofi and Novo Nordisk are doing is interesting. Both have an offer where for $99 you can get both basal AND bolus insulin (Toujeo and Apidra, or Tresiba and Fiasp or Novolog). This clever because it disadvantages manufacturer making only a meal time insulin (although I think the real target here is Eli Lilly rather than Mannkind) as their customers still need to buy a basal insulin which makes that route a lot more expensive. what? can you say that so dumb dumb over here can understand what you are saying? also, can you throw up the links to these offers? |
|
|
|
Post by peppy on Sept 14, 2019 11:27:47 GMT -5
Wow peppy. "I don't like your posts so please kill yourself." Sounds disproportionate to the "crime". you read me like a book.  |
|
|
|
Post by mytakeonit on Sept 14, 2019 12:00:59 GMT -5
Will the real #NastyWomen please stand up. Gotta love her.
So, reading between the lines ... I see peppy is saying that Afrezza inhalable insulin is on one side ... versus the other insulins being equal to vaping.
But, that's mytakeonit
|
|
paul
Researcher
Posts: 134
|
Post by paul on Sept 14, 2019 12:35:15 GMT -5
What Sanofi and Novo Nordisk are doing is interesting. Both have an offer where for $99 you can get both basal AND bolus insulin (Toujeo and Apidra, or Tresiba and Fiasp or Novolog). This clever because it disadvantages manufacturer making only a meal time insulin (although I think the real target here is Eli Lilly rather than Mannkind) as their customers still need to buy a basal insulin which makes that route a lot more expensive. what? can you say that so dumb dumb over here can understand what you are saying? also, can you throw up the links to these offers?
"Flat Rate of $99/month for Insulin and NovoLog at Half Price: New Insulin Offers in the US from Novo Nordisk"
"Using the Cash Card Program, people with diabetes will be able to purchase up to three vials or two packs of FlexPen/FlexTouch pens with any combination of Novo Nordisk analog insulins (NovoLog, Tresiba, Fiasp) for $99. Depending on the brand, this is about 3000-3600 units of insulin. The press release suggests that this amount will cover the monthly needs of most people with diabetes. There is no limit to the number of cards people may use in a given timeframe."
|
|
|
|
Post by agedhippie on Sept 14, 2019 15:54:37 GMT -5
What Sanofi and Novo Nordisk are doing is interesting. Both have an offer where for $99 you can get both basal AND bolus insulin (Toujeo and Apidra, or Tresiba and Fiasp or Novolog). This clever because it disadvantages manufacturer making only a meal time insulin (although I think the real target here is Eli Lilly rather than Mannkind) as their customers still need to buy a basal insulin which makes that route a lot more expensive. what? can you say that so dumb dumb over here can understand what you are saying? also, can you throw up the links to these offers? Sanofi: Insulins Valyou Savings Program. This is good for a mixture of 10 pen packs and vials per month for $99 which is a lot of insulin. That would last me nearly 3 months. Novo Nordisk: The link Paul gave is good. This is not available until the New Year (Jan 2nd) and only covers 2 boxes for $99, but again you can mix and match insulins. That's a lot less generous than Sanofi, but still enough for a month. If I didn't have insurance I would probably go for the Sanofi deal getting Toujeo and Apidra. Max that out every other month and it would cost me about $50 per month for everything which looks pretty good. From an Afrezza standpoint I would go for the Sanofi deal, buy 10 boxes of Toujeo for $99 and that would cover my basal insulin for a year. Combine that with Eagle Pharmacy at the $150 (270 cartridge) price point which I reckon would last me 2 months if I maxed it out, only dosed once per meal, and hit the perfect combination of sizes. The prices for a month would be $33 with Sanofi (actually less, but I am to idle to calculate the exact number), $99 with Novo Nordisk, and $83 for Afrezza and Toujeo (150/2 + 99/12). The Afrezza price assumes you do not do follow on dosing as if you do the price rises to $158 per month. |
|
|
|
Post by peppy on Sept 14, 2019 18:30:30 GMT -5
what? can you say that so dumb dumb over here can understand what you are saying? also, can you throw up the links to these offers? Sanofi: Insulins Valyou Savings Program. This is good for a mixture of 10 pen packs and vials per month for $99 which is a lot of insulin. That would last me nearly 3 months. Novo Nordisk: The link Paul gave is good. This is not available until the New Year (Jan 2nd) and only covers 2 boxes for $99, but again you can mix and match insulins. That's a lot less generous than Sanofi, but still enough for a month. If I didn't have insurance I would probably go for the Sanofi deal getting Toujeo and Apidra. Max that out every other month and it would cost me about $50 per month for everything which looks pretty good. From an Afrezza standpoint I would go for the Sanofi deal, buy 10 boxes of Toujeo for $99 and that would cover my basal insulin for a year. Combine that with Eagle Pharmacy at the $150 (270 cartridge) price point which I reckon would last me 2 months if I maxed it out, only dosed once per meal, and hit the perfect combination of sizes. The prices for a month would be $33 with Sanofi (actually less, but I am to idle to calculate the exact number), $99 with Novo Nordisk, and $83 for Afrezza and Toujeo (150/2 + 99/12). The Afrezza price assumes you do not do follow on dosing as if you do the price rises to $158 per month.
thank you old buddy old pal. $158 a months sounds pretty darn good. Got to do the followup dosing. |
|
|
|
Post by MnkdWASmyRtrmntPlan on Sept 14, 2019 21:28:20 GMT -5
|
|
|
|
Post by agedhippie on Sept 14, 2019 21:49:53 GMT -5
Sanofi: Insulins Valyou Savings Program. This is good for a mixture of 10 pen packs and vials per month for $99 which is a lot of insulin. That would last me nearly 3 months. Novo Nordisk: The link Paul gave is good. This is not available until the New Year (Jan 2nd) and only covers 2 boxes for $99, but again you can mix and match insulins. That's a lot less generous than Sanofi, but still enough for a month. If I didn't have insurance I would probably go for the Sanofi deal getting Toujeo and Apidra. Max that out every other month and it would cost me about $50 per month for everything which looks pretty good. From an Afrezza standpoint I would go for the Sanofi deal, buy 10 boxes of Toujeo for $99 and that would cover my basal insulin for a year. Combine that with Eagle Pharmacy at the $150 (270 cartridge) price point which I reckon would last me 2 months if I maxed it out, only dosed once per meal, and hit the perfect combination of sizes. The prices for a month would be $33 with Sanofi (actually less, but I am to idle to calculate the exact number), $99 with Novo Nordisk, and $83 for Afrezza and Toujeo (150/2 + 99/12). The Afrezza price assumes you do not do follow on dosing as if you do the price rises to $158 per month.
thank you old buddy old pal. $158 a months sounds pretty darn good. Got to do the followup dosing. You want Afrezza and you don't have or cannot get Afrezza that's the path to go. Over a year though it ends up being $1500 more than Sanofi's deal. If money is tight that will matter. |
|
|
|
Post by peppy on Sept 15, 2019 10:19:40 GMT -5
thank you old buddy old pal. $158 a months sounds pretty darn good. Got to do the followup dosing. You want Afrezza and you don't have or cannot get Afrezza that's the path to go. Over a year though it ends up being $1500 more than Sanofi's deal. If money is tight that will matter. honey if money is tight and you are a type one with no health insurance in this country and you still want to live, you are at Walmart buying the regular insulin playing Russian roulette. so what we need is another airliner. GDP and all. |
|
|
|
Post by shawnonafrezza on Sept 15, 2019 10:49:36 GMT -5
Peppy, I think you greatly overestimate how dangerous insulin is. People lived off of Regular and NPH for decades and animal insulin before that. I know many who still do by choice, they'd hardly call it russian roulette. Is any injectable insulin perfect? No. Is it the worst thing ever? No. Is Afrezza better? Depends who you ask. Over on FB some people are feeling enslaved to their CGM. Is that better or worse? Forced to split doses. Better or worse?
Take off the rose tinted glasses and look objectively at the life, not the insulin and you'll see different pros and cons. Nothing is "good", just different levels of livable.
|
|
|
|
Post by peppy on Sept 15, 2019 12:41:34 GMT -5
Peppy, I think you greatly overestimate how dangerous insulin is. People lived off of Regular and NPH for decades and animal insulin before that. I know many who still do by choice, they'd hardly call it russian roulette. Is any injectable insulin perfect? No. Is it the worst thing ever? No. Is Afrezza better? Depends who you ask. Over on FB some people are feeling enslaved to their CGM. Is that better or worse? Forced to split doses. Better or worse? Take off the rose tinted glasses and look objectively at the life, not the insulin and you'll see different pros and cons. Nothing is "good", just different levels of livable. Shawn I know you are correct. as far as over estimating how dangerous insulin is, you know a lot more than I ever want to. "Over on FB some people are feeling enslaved to their CGM." Molly told me her father used to have to boil his syringes and needles. Probably animal insulin back then. Things have changed over time. so everything is good then? You are not burning out? Molly died in her 40's of a heart attack. I finally learned what c peptide is, the c branch is taken off the insulin and the blood level is checked?  |
|
|
|
Post by peppy on Sept 15, 2019 12:46:20 GMT -5
Not an Afrezza user. A sensor problem as well. Mom is having a difficult time dealing with this. You know her child. shawnonafrezza, rose colored glasses, well, really just reading the CGM's/vital signs. you know, how when you are in the hospital and you expect your staff nurse to have a gauge on how you are doing? They use instruments that are found in hospitals, heart, respiratory and BP monitors, ventilators, lab tests, oxygen, antibiotics... Now the instrument CGM can be used as a gauge. I am tricky. I read the instrument. ALTHOUGH, the instrument has to be working properly. Now you wouldn't want your nurse to miss the part where your urine output has fallen off, your respiratory rate is up, your breathing is labored, and miss telling the physician. (That you are laying there like a wet rag and you need blood cultures would you?) Love ya.  |
|
|
|
Post by peppy on Sept 15, 2019 13:05:46 GMT -5
more rose colored glasses.  |
|
|
|
Post by agedhippie on Sept 15, 2019 13:08:56 GMT -5
And there you see a benefit of open source tools for diabetes. XDrip has language support for a whole heap of languages because people do the translation and donate it - no regulatory approvals, no delay. I had a relative who was one of the first people on insulin, and they died in their 80s with no complications. My mother remembers them because when she was a child they were a favorite of hers because they always had biscuits on them. The only advantage of the Walmart insulin now is that you don't need a prescription. The Sanofi deal is actually a lot cheaper! |
|
